The improvement of cardiac functions of αMyHC-MCP-1 suffering from inflammatory DCM by MSC suggested that MSC pathogenetically influence relevant processes in the diseased heart probably by a mechanism that controls inflammatory responses. The gene discussed is CCL2; the disease is familial dilated cardiomyopathy.